Back
ESC2025 Premium Access

Comparative clinical outcomes on renal function and mortality of uricosuric agents versus xanthine oxidase inhibitors in patients with hyperuricemia and cardiovascular risks

Session: Using big data to drive cardiovascular innovations
Topic: Big Data analysis
Speaker: Doctor A. Wada (Kusatsu, JP)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Atsuyuki Wada

Omi Medical Center, Kusatsu (Japan)
0 follower

5 more presentations in this session

The continuity of care in primary care improves prognosis in patients referred to a cardiology department

Speaker: Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Development and implementation of a heart failure dashboard for England: nationwide analysis of 1.4 million primary and secondary health care records

Speaker: Professor C. Gale (Leeds, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Development and validation of a nomogram model for all-cause mortality risk in patients with acute myocardial infarction complicated by impaired activity daily living

Speaker: Doctor Y. Zhang (Tianjin, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Potential real-world benefit of semaglutide 2.4 mg on cardiovascular outcomes in the UK based on the SELECT trial

Speaker: Doctor F. Fusco (Copenhagen, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Clinical profiles and temporal trends of 37,741 cardiovascular hospitalizations in greece over 13 years: initial insights from the CardioMining-AI nationwide database

Speaker: Doctor A. Samaras (Thessaloniki, GR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Using big data to drive cardiovascular innovations

Speakers: Doctor A. Wada, Doctor J. Gonzalez Juanatey, Professor C. Gale, Doctor Y. Zhang, Doctor F. Fusco...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources